Ketamine is on the World Health Organization’s List of Essential Medicines, which lists the most efficacious, safe and cost-effective medicines for priority conditions, indicating a favorable safety profile. Patients screened for oral KAP must meet a minimum set of safety criteria with clearly-outlined contraindications that preclude treatment.
Before KAP, vital signs are reviewed to ensure blood pressure and heart rate are within designated ranges.
The most common side effects associated with ketamine are nausea, vomiting, dizziness, diplopia, drowsiness, dysphoria, and confusion. Because ketamine can elicit dissociation, patients are prohibited from driving and are recommended for escort back home following treatment. Our protocol is designed to minimize the likelihood of experiencing unwanted effects.